GHIAA

Access commitments at funding don't automatically carry into manufacturing or procurement without specific provisions. That's the coordination challenge in global health partnerships. Explore our guidance: ghiaa.org/mapguide-home/… #GlobalHealth #EquitableAccess

How do you turn access policy into enforceable agreements? Our Toolkit now covers funding + licensing—IPR, tech transfer, supply commitments & more. ghiaa.org/mapguide-home/… #GlobalHealth #EquitableAccess

NEW: Our Equitable Access Toolkit now covers funding + licensing agreements—the full R&D-to-commercialization journey, Patent licenses, Tech transfer and Manufacturing. 🔗 ghiaa.org/mapguide-home/… #GlobalHealth #EquitableAccess

Our ED Julia Barnes-Weise joins experts from @UKHSA at #WorldVaccineCongress Washington (April 1) to examine real-world PPP models for pandemic readiness & biosecurity. 📍 Walter E. Washington Convention Center 🔗 terrapinn.com/conference/wor… #GlobalHealth #MAPGuide #Biosecurity

Happening today: GHIAA's Julia Barnes-Weise joins experts on voluntary licensing frameworks in global health. How can incentive mechanisms better align licensing with equitable access? 11AM Chile / 3PM Europe Register: us06web.zoom.us/meeting/regist… #GlobalHealth #Equitableaccess

Happening today: GHIAA's Julia Barnes-Weise joins experts on voluntary licensing frameworks in global health. How can incentive mechanisms better align licensing with equitable access? 11AM Chile / 3PM Europe Register: us06web.zoom.us/meeting/regist… #GlobalHealth

Feb 3: GHIAA's Julia Barnes-Weise joins experts examining how voluntary licensing frameworks can better deliver equitable access. Panel explores incentive mechanisms that translate policy into enforceable contracts. Register: us06web.zoom.us/meeting/regist… #GlobalHealth #EquitableAccess

Our year at the table and the work ahead - mailchi.mp/979bc51368a7/g…

Our year at the table and the work ahead - mailchi.mp/979bc51368a7/g…

New Licensing Insights + WHO Pandemic Agreement Updates. - mailchi.mp/bd13beacfafb/g…

New Licensing Insights + WHO Pandemic Agreement Updates. - mailchi.mp/bd13beacfafb/g…

Deepening Access Conversations: October Updates from GHIAA - mailchi.mp/90760a9b756c/g…

Deepening Access Conversations: October Updates from GHIAA - mailchi.mp/90760a9b756c/g…

New on the MAPGuide 📖 Protalix BioTherapeutics & Fiocruz (Brazil) sign a technology transfer and supply agreement for enzyme replacement therapy for Gaucher Disease. 🔗 ghiaa.org/mapguide-home/… #MAPGuide #GlobalHealth #TechnologyTransfer

📚 Have you checked out what we read last month? @EU_HaDEA 2025 #EU4Health calls on crisis preparedness are open until Dec 4, 2025 🗓️ 💊 CBRN countermeasures 🧥 Reusable PPE 🧪 Vector-borne disease diagnostics Discover more & subscribe →linkedin.com/pulse/policies… #GlobalHealth

New on the MAPGuide 📖 Harvard University & Tectonic Therapeutic sign a license covering patent rights and discovery materials. Includes provisions on affordable pricing, sub-licensing, and patent management in Developing Countries. 🔗Read more here ghiaa.org/mapguide-home/…

🎥 In case you missed it: Our ED Julia Barnes-Weise joined experts Ana Ayala, Ximena Benavides Reverditto & Jacob Madden at the National Vaccine Law Conference to reimagine global health security. Watch the full panel 🎬 👇 🔗 lnkd.in/dMZHw8Vk #GlobalHealth

Our September Newsletter is here! ✅ Julia’s reflections on global convenings ✅ New MAPGuide agreements ✅ Highlights from the Vaccine Law Conference (with recording) ✅ Meet our new Comms Manager 🔗 linkedin.com/pulse/policies… #GlobalHealth #AccessToMedicines #HealthEquity #GHIAA

From Vaccine Law to Vector Control. - mailchi.mp/ae9cd3718099/g…

From Vaccine Law to Vector Control. - mailchi.mp/ae9cd3718099/g…